미국의 의료용 영상진단기기 시장 : 규모, 점유율 및 동향 분석(2024-2030년) : MedSuite

Medical Imaging Device Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: X-Ray Imaging, Breast Imaging, and 5 more

한글목차

2023년 미국의 의료용 영상진단기기 시장 규모는 90억 달러에 달했습니다. 향후 2.7%의 연평균 성장률(CAGR)로 확대되어 예측 기간 동안 109억 달러에 달할 것으로 예상됩니다.

만성질환의 급증과 그 영향에 대한 인식이 높아짐에 따라 영상 시장의 성장을 가속하는 중요한 요인이 되고 있습니다. 만성 질환의 유행으로 인해 정확하고 시기적절한 진단, 지속적인 질병 모니터링 및 치료 효과 평가에 대한 요구가 증가하고 있습니다. 만성질환은 일반적으로 천천히 진행되기 때문에 효과적인 관리를 위해서는 조기 발견이 중요한데, MRI, CT 스캔, 초음파 등 첨단 영상진단 기술을 통해 의료진은 만성질환이 심각해지기 전에 초기 징후를 발견할 수 있습니다. 이러한 조기 발견은 적시에 개입할 수 있게 하여 궁극적으로 치료 결과를 개선하고 환자의 삶의 질을 향상시킬 수 있습니다.

2023년 GE헬스케어는 미국의 의료용 영상진단기기 시장의 선두주자로 부상하여 모든 영상 분야에서 독보적인 위치를 차지하고 있으며, GE는 엑스레이, 초음파, 핵의학 분야에서 독보적인 위치를 차지하고 있습니다.

지멘스 헬시니어스는 자기공명영상장치(MRI)와 컴퓨터단층촬영장치(CT) 시장에서 2023년 전체 영상진단 시장 2위 자리를 확보했습니다. 또한 엑스레이, 유방 영상, 초음파, 핵의학 시장에도 적극적으로 진출했습니다.

Philips Healthcare는 2023년 종합 이미징 시장에서 3번째로 주요한 진입자로 자리매김했으며, X-ray, 유방 영상, MRI, 초음파, CT 시장 등 다양한 영역에서 경쟁했습니다.

<미국의 의료용 영상진단기기 시장에 대해 조사했으며, 시장 개요와 함께 부문별 동향, 코로나19의 영향 분석, 시장 성장 촉진요인 및 저해요인, 경쟁사 시장 점유율 분석, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

주요 요약

조사 방법

COVID-19가 미국 의료용 영상 진단기기 시장에 미치는 영향

• 서론
• 시장 부문별 분석

제품 평가

• 서론
• 제품 포트폴리오
• 규제 문제와 리콜
• 임상시험

미국 의료용 영상 시장 개요

• 서론
• 시장 개요와 동향 분석
• 성장 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 경쟁 시장 점유율 분석
• 인수합병(M&A)
• 기업 개요
  • Bayer
  • Canon Medical
  • Fujifilm
  • GE Healthcare
  • Hologic
  • Philips Healthcare
  • Siemens Healthineers
• SWOT 분석

시술 건수

• 서론
• 시술

X선화상시장

유방 영상 시장

자기공명영상 시장

초음파 영상 시장

컴퓨터 단층촬영 영상 시장

핵의학 이미징 시장

조영제 및 인젝터 영상 처리 시장

약어

LSH

영문 목차

영문목차

In 2023, the U.S. medical imaging market achieved a valuation of $9.0 billion, with a projected growth rate of 2.7% at a Compound Annual Growth Rate (CAGR), the market is anticipated to reach $10.9 billion during the forecast period.

Our comprehensive report suite on the U.S. Medical Imaging Market encompasses a diverse spectrum of over 60 companies in the United States. It encompasses X-ray imaging, breast imaging, magnetic resonance imaging (MRI), ultrasound equipment, computed tomography (CT) imaging, nuclear medicine imaging, and contrast agents and injectors.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Procedure Numbers, Average Selling Prices, Market Size & Growth Trends
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2030, and Historical Data to 2020
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

U.S. Medical Imaging Market Insights

The surge in chronic diseases and the increased recognition of their consequences serve as significant drivers fueling the growth of the imaging market. As chronic illnesses become more prevalent, there is an increasing need for accurate and timely diagnosis, ongoing disease monitoring, and the evaluation of treatment effectiveness. Chronic conditions typically develop slowly, underscoring the crucial role of early detection in effective management. Advanced imaging technologies such as MRI, CT scans, and ultrasound empower healthcare providers to identify the initial signs of chronic diseases before they advance to more severe stages. This early identification enables timely intervention, ultimately leading to improved treatment outcomes and an enhanced quality of life for patients.

U.S. Medical Imaging Market Share Insights

In 2023, GE Healthcare emerged as the frontrunner in the U.S. imaging market, holding a unique position as the sole contender in every imaging segment. GE dominated the X-ray, ultrasound, and nuclear medicine sectors.

Securing the second spot in the overall imaging market for 2023, Siemens Healthineers excelled in the magnetic resonance imaging (MRI) and computed tomography (CT) markets. The company also actively participated in the X-ray, breast imaging, ultrasound, and nuclear medicine markets.

Philips Healthcare, positioned as the third major player in the comprehensive imaging market in 2023, competed across various domains, including X-ray, breast imaging, MRI, ultrasound, and CT markets.

MARKET SEGMENTATION SUMMARY

X-Ray Imaging Market - includes analog, computed radiography (CR), digital radiography (DR), fluoroscopy and cardiovascular X-ray systems.

Breast Imaging Market - includes mammography, molecular breast imaging (MBI), breast ultrasound and breast magnetic resonance imaging (MRI) coil markets.

Magnetic Resonance Imaging Market - includes low-, mid- and high-field MRI systems as well as closed-bore and wide-bore MRIs of any field strength.

Ultrasound Imaging Market - segmented into: equipment for cardiology, radiology, obstetrics and gynecology (OB/GYN), urology, surgery, vascular, ophthalmic and point of care (POC).

Computed Tomography Imaging Market - includes 16/20, 32/40, 64 and ultra-premium slice scanners.

Nuclear Medicine Imaging Market - includes positron emission tomography/computed tomography (PET/CT), single photon emission computed tomography (SPECT) and single photon emission computed tomography/computed tomography (SPECT/CT).

Contrast Agent and Injector Imaging Market - includes X-ray and computed tomography (CT) agents, magnetic resonance imaging (MRI) agents and ultrasound agents as well as contrast injectors.

Research Scope Summary

Report Attribute

• Regions: United States
• Base Year: 2023
• Forecast: 2024-2030
• Historical Data: 2020-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

TABLE OF CONTENT

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

• U.S. MEDICAL IMAGING DEVICE MARKET OVERVIEW
• COMPETITIVE ANALYSIS
• MARKET TRENDS
• MARKET DEVELOPMENTS
• PROCEDURES INCLUDED
• PROCEDURE CODES INVESTIGATED
• MARKETS INCLUDED
• KEY REPORT UPDATES
• VERSION HISTORY

RESEARCH METHODOLOGY

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

IMPACT OF COVID-19 ON THE U.S. MEDICAL IMAGING MARKET

• 2.1. INTRODUCTION
• 2.2. ANALYSIS BY MARKET SEGMENT
  • 2.2.1. Worst Case Scenario
  • 2.2.2. Base Case Scenario
  • 2.2.3. Best Case Scenario

PRODUCT ASSESSMENT

• 3.1. INTRODUCTION
• 3.2. PRODUCT PORTFOLIOS
  • 3.2.1. X-ray Imaging Market
    • 3.2.1.1. Analog X-ray Devices
    • 3.2.1.2. Computed Radiography X-ray Devices
    • 3.2.1.3. Digital Radiography X-ray Devices
    • 3.2.1.4. Fluoroscopy Devices
    • 3.2.1.5. Cardiovascular X-ray Devices
  • 3.2.2. Breast Imaging Market
    • 3.2.2.1. Mammography
    • 3.2.2.1.1. Computed Radiography Mammography Devices
    • 3.2.2.1.2. Digital Radiography Mammography Devices
    • 3.2.2.1.3. Digital Breast Tomosynthesis Devices
    • 3.2.2.2. Molecular Breast Imaging
    • 3.2.2.2.1. Positron Emission Mammography Devices
    • 3.2.2.2.2. Gamma Imaging Devices
    • 3.2.2.3. Breast Ultrasound
    • 3.2.2.4. MRI Coil Market
  • 3.2.3. Magnetic Resonance Imaging Market
    • 3.2.3.1. Closed-Bore vs. Wide-Bore Systems
  • 3.2.4. Ultrasound Imaging Market
    • 3.2.4.1. Cardiology Ultrasound Devices
    • 3.2.4.2. Radiology Ultrasound Devices
    • 3.2.4.3. OB/GYN Ultrasound Devices
    • 3.2.4.4. Urology Ultrasound Devices
    • 3.2.4.5. Surgery Ultrasound Devices
    • 3.2.4.6. Vascular Ultrasound Devices
    • 3.2.4.7. Ophthalmic Ultrasound Devices
    • 3.2.4.8. Point-of-Care Ultrasound Imaging Devices
  • 3.2.5. Computed Tomography Imaging Market
  • 3.2.6. Nuclear Medicine Imaging Market
    • 3.2.6.1. PET/CT
    • 3.2.6.2. SPECT
    • 3.2.6.3. SPECT/CT Devices
  • 3.2.7. Contrast Agent and Injector Market
    • 3.2.7.1. X-ray and CT
    • 3.2.7.2. MRI
    • 3.2.7.3. Ultrasound
    • 3.2.7.4. Contrast Injector
• 3.3. REGULATORY ISSUES AND RECALLS
  • 3.3.1. X-ray Imaging Market FDA Recalls
  • 3.3.2. Breast Imaging Market FDA Recalls
  • 3.3.3. Magnetic Resonance Imaging Market FDA Recalls
  • 3.3.4. Ultrasound Imaging Market FDA Recalls
  • 3.3.5. Computed Tomography Imaging Market FDA Recalls
  • 3.3.6. Nuclear Medicine Imaging Market FDA Recalls
  • 3.3.7. Contrast Agent and Injector Market FDA Recalls
• 3.4. CLINICAL TRIALS
  • 3.4.1. X-ray Imaging Market Clinical Trials
  • 3.4.2. Breast Imaging Market Clinical Trials
  • 3.4.3. Magnetic Resonance Imaging Market Clinical Trials
  • 3.4.4. Ultrasound Imaging Market Clinical Trials
  • 3.4.5. Computed Tomography Imaging Market Clinical Trials
  • 3.4.6. Nuclear Medicine Imaging Market Clinical Trials
  • 3.4.7. Contrast Agent and Injector Market Clinical Trials

U.S. MEDICAL IMAGING MARKET OVERVIEW

• 4.1. INTRODUCTION
• 4.2. MARKET OVERVIEW & TREND ANALYSIS
• 4.3. DRIVERS AND LIMITERS
  • 4.3.1. Market Drivers
  • 4.3.2. Market Limiters
• 4.4. COMPETITIVE MARKET SHARE ANALYSIS
• 4.5. MERGERS AND ACQUISITIONS
• 4.6. COMPANY PROFILES
  • 4.6.1. Bayer
  • 4.6.2. Canon Medical
  • 4.6.3. Fujifilm
  • 4.6.4. GE Healthcare
  • 4.6.5. Hologic
  • 4.6.6. Philips Healthcare
  • 4.6.7. Siemens Healthineers
• 4.7. SWOT ANALYSIS
  • 4.7.1. Bayer
  • 4.7.2. Canon Medical
  • 4.7.3. Fujifilm
  • 4.7.4. GE Healthcare
  • 4.7.5. Hologic
  • 4.7.6. Philips Healthcare
  • 4.7.7. Siemens Healthineers

PROCEDURE NUMBERS

• 5.1. INTRODUCTION
• 5.2. PROCEDURES
  • 5.2.1. X-ray Procedures
    • 5.2.1.1. Diagnostic X-ray Procedures by Anatomy
    • 5.2.1.2. Fluoroscopy Procedures by Type
    • 5.2.1.3. Cardiovascular X-ray Procedures by Type
  • 5.2.2. Breast Imaging Procedures
  • 5.2.3. Magnetic Resonance Imaging Procedures
    • 5.2.3.1. Diagnostic Magnetic Resonance Imaging Procedures
    • 5.2.3.2. Magnetic Resonance Angiography Procedures
    • 5.2.3.3. Guidance Magnetic Resonance Imaging Procedures
    • 5.2.3.4. Intraoperative Magnetic Resonance Imaging Procedures
  • 5.2.4. Ultrasound Procedures
    • 5.2.4.1. Ultrasound Procedures
    • 5.2.4.1.1. Cardiac Ultrasound Procedures by Type
    • 5.2.4.2. Ultrasound Guidance Procedures
  • 5.2.5. Computed Tomography Procedures
    • 5.2.5.1. Diagnostic Computed Tomography Procedures by Anatomy
    • 5.2.5.2. Computed Tomography Angiography Procedures
    • 5.2.5.3. Computed Tomography Guidance Procedures
  • 5.2.6. Nuclear Medicine Procedures
    • 5.2.6.1. SPECT Procedures by Anatomy
    • 5.2.6.2. PET Procedures by Anatomy

X-RAY IMAGING MARKET

• 6.1. INTRODUCTION
• 6.2. MARKET OVERVIEW
• 6.3. MARKET ANALYSIS AND FORECAST
  • 6.3.1. Total X-ray Market
  • 6.3.2. Analog X-ray Market
  • 6.3.3. Computed Radiography X-ray Market
  • 6.3.4. Digital Radiography X-ray Market
  • 6.3.5. Fluoroscopy X-ray Market
  • 6.3.6. Cardiovascular X-ray Market
• 6.4. DRIVERS AND LIMITERS
  • 6.4.1. Market Drivers
  • 6.4.2. Market Limiters
• 6.5. COMPETITIVE MARKET SHARE ANALYSIS

BREAST IMAGING MARKET

• 7.1. INTRODUCTION
• 7.2. MARKET OVERVIEW
• 7.3. MARKET ANALYSIS AND FORECAST
  • 7.3.1. Total Mammography Market
    • 7.3.1.1. Computed Radiography Market
    • 7.3.1.2. Digital Radiography Market
    • 7.3.1.3. Digital Tomosynthesis Market
  • 7.3.2. Total Molecular Breast Imaging Market
    • 7.3.2.1. Positron Emission Mammography Market
    • 7.3.2.2. Gamma Imaging Market
  • 7.3.3. Total Breast Ultrasound Market
    • 7.3.3.1. Manual Breast Ultrasound Market
    • 7.3.3.2. Automated Breast Ultrasound Market
  • 7.3.4. MRI Coil Market
• 7.4. DRIVERS AND LIMITERS
  • 7.4.1. Market Drivers
  • 7.4.2. Market Limiters
• 7.5. COMPETITIVE MARKET SHARE ANALYSIS

MAGNETIC RESONANCE IMAGING MARKET

• 8.1. INTRODUCTION
• 8.2. MARKET OVERVIEW
• 8.3. MARKET ANALYSIS AND FORECAST
  • 8.3.1. Total Closed-Bore MRI Market
    • 8.3.1.1. Low-Field Closed-Bore MRI Market
    • 8.3.1.2. Mid-Field Closed-Bore MRI Market
    • 8.3.1.3. High-Field Closed-Bore MRI Market
  • 8.3.2. Total Wide-Bore MRI Market
    • 8.3.2.1. Low-Field Wide-Bore MRI Market
    • 8.3.2.2. Mid-Field Wide-Bore MRI Market
    • 8.3.2.3. High-Field Wide-Bore MRI Market
• 8.4. DRIVERS AND LIMITERS
  • 8.4.1. Market Drivers
  • 8.4.2. Market Limiters
• 8.5. COMPETITIVE MARKET SHARE ANALYSIS

ULTRASOUND IMAGING MARKET

• 9.1. INTRODUCTION
• 9.2. MARKET OVERVIEW
• 9.3. MARKET ANALYSIS AND FORECAST
  • 9.3.1. Total Ultrasound Imaging Market
  • 9.3.2. Cardiology Ultrasound Market
    • 9.3.2.1. Cardiology Ultrasound Market by Type
    • 9.3.2.1.1. High-End Cardiology Ultrasound Market
    • 9.3.2.1.2. Hand-Carried Cardiology Ultrasound Market
    • 9.3.2.2. Cardiology Ultrasound Market by Setting
    • 9.3.2.2.1. Hospital Cardiology Ultrasound Market
    • 9.3.2.2.2. Office Cardiology Ultrasound Market
  • 9.3.3. Radiology Ultrasound Market
    • 9.3.3.1. Radiology Ultrasound Market by Type
    • 9.3.3.1.1. High-End Radiology Ultrasound Market
    • 9.3.3.1.2. Hand-Carried Radiology Ultrasound Market
    • 9.3.3.2. Radiology Ultrasound Market by Setting
    • 9.3.3.2.1. Hospital Radiology Ultrasound Market
    • 9.3.3.2.2. Office Radiology Ultrasound Market
  • 9.3.4. Obstetrics and Gynecology Ultrasound Market
    • 9.3.4.1. Obstetrics and Gynecology Ultrasound Market by Type
    • 9.3.4.1.1. High-End Obstetrics and Gynecology Ultrasound Market
    • 9.3.4.1.2. Hand-Carried Obstetrics and Gynecology Ultrasound Market
    • 9.3.4.2. Obstetrics and Gynecology Ultrasound Market by Setting
    • 9.3.4.2.1. Hospital Obstetrics and Gynecology Ultrasound Market
    • 9.3.4.2.2. Office Obstetrics and Gynecology Ultrasound Market
  • 9.3.5. Urology Ultrasound Market
    • 9.3.5.1. Urology Ultrasound Market by Type
    • 9.3.5.1.1. High-End Urology Ultrasound Market
    • 9.3.5.1.2. Hand-Carried Urology Ultrasound Market
    • 9.3.5.2. Urology Ultrasound Market by Setting
    • 9.3.5.2.1. Hospital Urology Ultrasound Market
    • 9.3.5.2.2. Office Urology Ultrasound Market
  • 9.3.6. Surgery Ultrasound Market
  • 9.3.7. Vascular Ultrasound Market
  • 9.3.8. Ophthalmic Ultrasound Market
    • 9.3.8.1. Pachymeter Ophthalmic Ultrasound Market
    • 9.3.8.2. A-Scan Ultrasound Market
    • 9.3.8.3. B-Scan Ultrasound Market
    • 9.3.8.4. A/B Scan Ultrasound Market
    • 9.3.8.5. Ultrasound Biomicroscope Market
  • 9.3.9. Point-of-Care Ultrasound Market
    • 9.3.9.1. Emergency Medicine Point-of-Care Ultrasound Imaging
    • 9.3.9.1.1. Emergency Medicine Point-of-Care Ultrasound by Device Type
    • 9.3.9.2. Total Anesthesia Ultrasound Market
    • 9.3.9.2.1. Anesthesia Ultrasound Equipment Market by Type
    • 9.3.9.2.2. Anesthesia Ultrasound Equipment Market by Function
    • 9.3.9.3. Critical Care Ultrasound Market
    • 9.3.9.3.1. Critical Care Ultrasound Market by Type
    • 9.3.9.4. Musculoskeletal Ultrasound Market
    • 9.3.9.5. Other Point-of-Care Ultrasound Market
• 9.4. DRIVERS AND LIMITERS
  • 9.4.1. Market Drivers
  • 9.4.2. Market Limiters
• 9.5. COMPETITIVE MARKET SHARE ANALYSIS

COMPUTED TOMOGRAPHY IMAGING MARKET

• 10.1. INTRODUCTION
• 10.2. MARKET OVERVIEW
• 10.3. MARKET ANALYSIS AND FORECAST
  • 10.3.1. Total Computed Tomography Imaging Market
  • 10.3.2. 16/20 Slice Market
  • 10.3.3. 32/40 Slice Market
  • 10.3.4. 64 Slice Market
  • 10.3.5. Ultra-Premium Slice Market
• 10.4. DRIVERS AND LIMITERS
  • 10.4.1. Market Drivers
  • 10.4.2. Market Limiters
• 10.5. COMPETITIVE MARKET SHARE ANALYSIS

NUCLEAR MEDICINE IMAGING MARKET

• 11.1. INTRODUCTION
• 11.2. MARKET OVERVIEW
• 11.3. MARKET ANALYSIS AND FORECAST
  • 11.3.1. PET/CT Nuclear Medicine Imaging Market
  • 11.3.2. SPECT Nuclear Medicine Imaging Market
  • 11.3.3. SPECT/CT Nuclear Medicine Imaging Market
• 11.4. DRIVERS AND LIMITERS
  • 11.4.1. Market Drivers
  • 11.4.2. Market Limiters
• 11.5. COMPETITIVE MARKET SHARE ANALYSIS

CONTRAST AGENT AND INJECTOR IMAGING MARKET

• 12.1. INTRODUCTION
• 12.2. MARKET OVERVIEW
• 12.3. MARKET ANALYSIS AND FORECAST
  • 12.3.1. Total Contrast Agent Market
    • 12.3.1.1. X-ray/CT Contrast Agent Market
    • 12.3.1.2. MRI Contrast Agent Market
    • 12.3.1.3. Ultrasound Contrast Agent Market
  • 12.3.2. Contrast Injector Market
• 12.4. DRIVERS AND LIMITERS
  • 12.4.1. Market Drivers
  • 12.4.2. Market Limiters
• 12.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

관련자료